GAMIAN-Europe is supporting the PROBIP study, an international multilingual research project led by Dr. Astrid Chevance (CRESS – Inserm Université Paris Cité). The aim of the study is to identify which outcomes matter most to people with lived experience of bipolar disorder, in order to improve how treatment effectiveness is evaluated across clinical and psychosocial care. The study covers outcomes related to pharmacological, psychological, neurostimulation, and psychosocial interventions.
Who can participate
- People living with bipolar disorder (type I, type II, or other bipolar spectrum conditions)
- Informal caregivers (family members, friends, or relatives)
- Healthcare professionals working with people affected by bipolar disorder
Study details
- Online anonymous questionnaire
- Takes less than 15 minutes to complete
- Fully confidential; no identifying information is collected
- Participants may save progress and return later if needed
Available languages
